H3 Biomedicine
H3 Biomedicine is a biopharmaceutical company focused on the discovery and early development of novel, targeted anti-cancer compounds for the unmet needs of genetically defined patient populations.
Overview
H3 Biomedicine, the U.S.-based precision oncology research and development subsidiary of Eisai Co., partnered with Dimella Shaffer, PDIC and Creative Office Resources along with our manufacturers Knoll, Muuto, Holoform to complete their office renovations on the 5th and 6th floors of 300 Technology Square in Cambridge. The new space includes 74 Knoll Dividends height adjustable workstations, multiple huddle, meeting and common areas in addition to 308 linear feet of Holoform glass walls.
Cambridge, MA / Locations
Dimella Shaffer, PIDC / Partners
Knoll, Muuto, Holoform / Furniture